Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Systemic lupus erythematosus
(
SLE
) is an autoimmune disorder with several clinical manifestations.
SLE
etiology has a strong genetic component, which plays a key role in disease's predisposition, as well as participation of environmental factors, such and UV light exposure. In this regard, we investigated whether polymorphisms in
STK17A
, a DNA repair related gene, encoding for serine/threonine-protein kinase 17A, are associated with
SLE
susceptibility. A total of 143
SLE
patients and 177 healthy controls from Southern Brazil were genotyped for five
STK17A
TagSNPs. Our results indicated association of rs7805969 SNP (A and G/A genotype, OR=1.40 and OR=1.73, respectively) with
SLE
predisposition and the following clinical manifestations: arthritis, cutaneous and immunological alterations. When analyzing haplotypes distribution, we found association between TGGTC, TAGTC and AAGAT haplotypes and risk to develop
SLE
. When considering clinical manifestations, the haplotypes TGGTT and TAGTC were associated with protection against cutaneous alterations and the haplotype TAGTC to hematological alterations. We also observed association between
SLE
clinical manifestations and ethnicity, with the European-derived patients being more susceptible to cutaneous and hematological alterations.
...
PMID:Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations. 2386 Mar 22